ELIZABETH MCLEISH: Open Payments
NPI 1013929389 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,078 in 137 payments from 14 companies in 2025. Trend: 2023 $2,566 · 2024 $2,668 · 2025 $2,078
Food & beverage: $2,068Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $505 |
| Janssen Biotech, Inc. | 25 | $444 |
| GENZYME CORPORATION | 8 | $262 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| UCB, Inc. | 7 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Amgen Inc. | 3 | $77 |
| Lilly USA, LLC | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Sotyktu, Bimzelx, RINVOQ, Otezla, Rhapsido.
Industry payments across MA — which companies pay providers there.
